Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model
Sumit Kumar(Chaudhary Charan Singh University), Alfred C.O. Vertegaal(Leiden University Medical Center)
Cited by 125
Related Papers
In Vivo Identification of Human Small Ubiquitin-like Modifier Polymerization Sites by High Accuracy Mass Spectrometry and an in Vitro to in Vivo Strategy
|Molecular & Cellular Proteomics|2007|299
System-wide identification of wild-type SUMO-2 conjugation sites
|Nature Communications|2015|119
RNF12 Controls Embryonic Stem Cell Fate and Morphogenesis in Zebrafish Embryos by Targeting Smad7 for Degradation
|Molecular Cell|2012|95
The MN1-TEL Fusion Protein, Encoded by the Translocation (12;22)(p13;q11) in Myeloid Leukemia, Is a Transcription Factor with Transforming Activity
|Molecular and Cellular Biology|2000|95